{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:53:10Z","timestamp":1791024790686,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.tox.2006.07.028","type":"journal-article","created":{"date-parts":[[2006,8,13]],"date-time":"2006-08-13T07:06:09Z","timestamp":1155452769000},"page":"120-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Development of next generation medical countermeasures to nerve agent poisoning"],"prefix":"10.1016","volume":"233","author":[{"given":"Janet","family":"Wetherell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Mumford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.tox.2006.07.028_bib1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1017\/S1049023X00001072","article-title":"Future considerations for the medical management of nerve-agent intoxication","volume":"18","author":"Aas","year":"2004","journal-title":"Spec. Rep. Prehosp. Disaster Med."},{"key":"10.1016\/j.tox.2006.07.028_bib2","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0006-2952(70)90256-X","article-title":"The use of carbamates and atropine in the protection of animals against poisoning by 1,2,-trimethylpropylmethylphosphonofluoridate","volume":"19","author":"Berry","year":"1970","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.tox.2006.07.028_bib3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1053\/jvet.2003.50027","article-title":"Microemulsified cyclosporine-based immunosuppression for the prevention of acute renal allograft rejection in unrelated dogs: Preliminary experimental study","volume":"32","author":"Bernsteen","year":"2003","journal-title":"Vet. Surg."},{"key":"10.1016\/j.tox.2006.07.028_bib4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.2042-7158.1979.tb13504.x","article-title":"The protection of primates against soman poisoning by pretreatment with pyridostigmine","volume":"31","author":"Dirnhuber","year":"1979","journal-title":"J. Pharm. Pharmacol."},{"issue":"5","key":"10.1016\/j.tox.2006.07.028_bib5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jat.2550140502","article-title":"Review of oximes available for treatment of nerve agent poisoning","volume":"14","author":"Dawson","year":"1994","journal-title":"J. Appl. Toxicol."},{"issue":"12","key":"10.1016\/j.tox.2006.07.028_bib6","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.2460\/javma.2003.222.1743","article-title":"Obstruction of the cecolic orifice by ileocecolic intussusception following jejunocecostomy in a horse","volume":"222","author":"Erkert","year":"2003","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.tox.2006.07.028_bib7","series-title":"FDA Guidelines in Guidance for Industry. Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers","author":"FDA","year":"2005"},{"issue":"2","key":"10.1016\/j.tox.2006.07.028_bib8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0197-0186(91)90194-I","article-title":"Effect of acute physostigmine\u2013hyoscine pre-treatment on the neurochemical changes produced by soman in the guinea-pig","volume":"18","author":"Fosbraey","year":"1990","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.tox.2006.07.028_bib9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0041-008X(77)90122-3","article-title":"The prophylactic use of 1-methyl,2-hydroxyiminomethylpyridinium methanesulphonate (P2S) in the treatment of organophosphate poisoning","volume":"40","author":"Gordon","year":"1977","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2006.07.028_bib10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0041-008X(78)80045-3","article-title":"The protection of animals against organophosphate poisoning by pretreatment with a carbamate","volume":"43","author":"Gordon","year":"1978","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"3","key":"10.1016\/j.tox.2006.07.028_bib11","first-page":"54","article-title":"Subtotal colon resection for intussusception of the left dorsal colon in an eleven years old Highland gelding","volume":"90","author":"Hainisch","year":"2003","journal-title":"Wien. Tierarztl. Monatsschr."},{"issue":"3","key":"10.1016\/j.tox.2006.07.028_bib12","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00210-006-0054-5","article-title":"The presence of atropinesterase activity in human plasma","volume":"373","author":"Harrison","year":"2006","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.tox.2006.07.028_bib13","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.2042-7158.1983.tb04316.x","article-title":"The efficacy of bispyridinium derivatives in the treatment of organophosphonate poisoning in the guinea-pig","volume":"35","author":"Inns","year":"1983","journal-title":"J. Pharm. Pharmacol."},{"issue":"8","key":"10.1016\/j.tox.2006.07.028_bib14","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1086\/367895","article-title":"Reappraisal of the association of intussusception with the licensed live rotavirus vaccine challenges initial conclusions","volume":"187","author":"Kapikian","year":"2003","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.tox.2006.07.028_bib15","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1081\/CLT-120015840","article-title":"Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents","volume":"40","author":"Kassa","year":"2002","journal-title":"J. Toxicol. Clin. Toxicol."},{"issue":"1","key":"10.1016\/j.tox.2006.07.028_bib16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0272-0590(90)90229-D","article-title":"Pharmacological and toxicological evaluation of orally administered pyridostigmine in dogs","volume":"14","author":"Kluwe","year":"1990","journal-title":"Fund. Appl. Toxicol."},{"key":"10.1016\/j.tox.2006.07.028_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0022-3565(25)05875-6","article-title":"Synergisms and antagonisms between physostigmine and di-isopropyl fluorophosphates in cats","volume":"88","author":"Koster","year":"1946","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2006.07.028_bib18","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1016\/0272-0590(85)90132-0","article-title":"Treatment of poisoning by soman","volume":"5","author":"Leadbeater","year":"1985","journal-title":"Fund. Appl. Toxicol."},{"issue":"3","key":"10.1016\/j.tox.2006.07.028_bib19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/08941930390205791","article-title":"Modified noble placation for the prevention of intestinal intussusception after renal transplantation in dogs","volume":"16","author":"Kyles","year":"2003","journal-title":"J. Invest. Surg."},{"key":"10.1016\/j.tox.2006.07.028_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-1211(99)00060-1","article-title":"Anticonvulsant treatment of nerve agent seizures: anticholinergics versus diazepam in soman-intoxicated guinea-pigs","volume":"38","author":"McDonough","year":"2000","journal-title":"Epilepsy Res."},{"issue":"8","key":"10.1016\/j.tox.2006.07.028_bib21","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1086\/367895","article-title":"Reappraisal of the association of intussusception with the licensed live rotavirus vaccine challenges initial conclusions","volume":"187","author":"Murphy","year":"2003","journal-title":"J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.tox.2006.07.028_bib22","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1086\/374420","article-title":"The first rotavirus vaccine and intussusception: epidemiological studies and policy decisions","volume":"187","author":"Murphy","year":"2003","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.tox.2006.07.028_bib23","first-page":"293","article-title":"Pyridinium and imidazolium salts as antidotes for soman and paraxon poisoning in rats","volume":"26","author":"Oldiges","year":"1970","journal-title":"Arch. Toxicol."},{"issue":"3","key":"10.1016\/j.tox.2006.07.028_bib24","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/01.inf.0000055064.76457.f3","article-title":"Intussusception-associated hospitalization among Venezuelan infants during 1998 through 2001: anticipating rotavirus vaccines","volume":"22","author":"Perez-Schael","year":"2003","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.tox.2006.07.028_bib25","series-title":"Proceedings of the CB Medical Treatment Symposium","article-title":"The current UK medical countermeasures for nerve agent poisoning; physostigmine and hyoscine as an alternative to pyridostigmine","author":"Scott","year":"1994"},{"issue":"Suppl. S","key":"10.1016\/j.tox.2006.07.028_bib26","first-page":"36","article-title":"Non-competitive block of the human muscle adult nicotinic acetylcholine receptor ion channel by the bispyridinium compounds, SAD-128 (SAD), toxogonin (TOX) and HI-6","volume":"12","author":"Sheridan","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.tox.2006.07.028_bib27","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/j.1476-5381.1993.tb13498.x","article-title":"Ion channel blockade by oximes and recovery of diaphragm muscle from soman poisoning in vitro","volume":"108","author":"Tattersall","year":"1983","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.tox.2006.07.028_bib28","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3109\/00498259109043204","article-title":"Metabolism in vivo of the tropans alkaloid, scopolamine, in several mammalian species","volume":"21","author":"Wada","year":"1991","journal-title":"Xenobiotica"},{"key":"10.1016\/j.tox.2006.07.028_bib29","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.2042-7158.1994.tb03260.x","article-title":"Continuous administration of low dose rates of physostigmine and hyoscine to guinea-pigs prevents the toxicity and reduces the incapacitation produced by soman poisoning","volume":"46","author":"Wetherell","year":"1994","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.tox.2006.07.028_bib30","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0161-813X(02)00082-7","article-title":"Physostigmine and hyoscine improves protection against the lethal and incapacitating effects of nerve agent poisoning in the guinea-pig","volume":"23","author":"Wetherell","year":"2002","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.tox.2006.07.028_bib31","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.neuro.2006.01.006","article-title":"A novel approach for medical countermeasures to nerve agent poisoning in the guinea-pig","volume":"27","author":"Wetherell","year":"2006","journal-title":"Neurotoxicology"}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X06004677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X06004677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:56:58Z","timestamp":1759532218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X06004677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":31,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0300483X06004677"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2006.07.028","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of next generation medical countermeasures to nerve agent poisoning","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2006.07.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2006 Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}